Tim Johnson

Tim Johnson is an experienced financial professional and leader with a diverse background in capital management and executive roles. Currently serving as a Partner at BroadOak Capital Partners since February 2015 and as Chief Executive Officer at Horizon Infusions since August 2019, Tim also holds positions as a Board Member at Science and Medicine Group and Chairman at LabConnect, both from 2017. Previous experience includes board roles at Pathology Inc and DrugScan, as well as a position as General Partner at Mt. Weather Capital from 2009 to 2017. Tim's earlier career includes a tenure as Managing Director at England & Company from 2004 to 2015 and as Audit Senior at Arthur Andersen & Co. from 1993 to 1996. Tim Johnson holds an MBA and a BS in Accounting, both from the University of Maryland, where Tim graduated Magna Cum Laude.